PBMA H V Desai
Completed Randomized Control Trial

Sponsor - Sun Pharmaceutical Ltd.

Protocol No:SUB/SFCB/0110
Protocol Title:- “Evaluation and efficacy and safety of two fixed dose combination of carbonic anhydrate inhibitor and beta blocker for the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma a randomized open label, comparative, multicentric study.”

Sponsor - Lotus Lab

Protocol No:- WAT/BNZL/2014
Protocol Title:- A multicentre, double blind, active controlled, parallel group, two arm, bioequivalence study with clinical endpoint comparing Brinzolamide 1% ophthalmic suspension (manufactured by Indoco Remedies Ltd., for Watson PharmaPvt Ltd.), to Brinzolamide (Azopt®) 1% ophthalmic suspension of Alcon Laboratories Inc., in the treatment of Chronic open angle glaucoma or Ocular hypertension in both eye.

Sponsor - Lotus Lab

Protocol No:- WAT/LTPNL/2015
Protocol Title:- An Open Label, Randomized, Multicentric, Two Treatment, Single Dose, Parallel Group Two Stage Adaptive Design Bioequivalence Study of Loteprednol Etabonate Ophthalmic Suspension, 0.5 % in Aqueous Humor of Patients Undergoing Indicated Cataract Surgery”

Sponsor – Alcon Laboratories India Pvt, Ltd.

Protocol No:- EXJ821-P001 (C-13-039)
Protocol Title:- Clinical Evaluation of Systane® Balance on Corneal Staining in Indian Subjects with Dry Eye.


PBMA's H. V. Desai Eye Hospital, 93, Tarwade Vasti, Mohammadwadi road, Hadapsar, Pune MH 411060 India

Contact No

+91-20-26970144 | 26970043

+91-20-30114000 | 30114201

Working Hours

Mon to Fri - 8:00 am to 4:00 pm
Mon to Fri - 5:00 pm to 7:00 pm
Saturday : 8:00 am to 2:00 pm
Sunday : Closed

Keep In Touch

We are happy to answer your questions at desaieyehospital@hvdeh.org

Copyright 2017 PBMA's H. V. Desai Eye Hospital
Best viewed in IE 10+, Firefox 20+, Chrome , Safari5+, Opera12+
Online Appointment
Go to Top